ASKLEPIOS BIOPHARMACEUTICAL

asklepios-biopharmaceutical-logo

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders and other rare diseases. It offers proprietary AAV technology, manufacturing capabilities, and a robust pipeline of in-house clinical programs for clients in the medical biopharmaceutical industry. Its pipeline includes clinical-stage programs in Pompe disease and congestive heart failure and a diverse preclinical portfolio of therapeutics targeting neuromuscular, C... NS, and other diseases, as well as out-licensed clinical indications for hemophilia and Duchenne muscular dystrophy. The companyโ€™s gene therapy platform includes Pro10, an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid, and promoter library. Asklepios BioPharmaceutical was founded in 2001 and is headquartered in Research Triangle Park, North Carolina.

#SimilarOrganizations #People #Financial #Event #Website #More

ASKLEPIOS BIOPHARMACEUTICAL

Industry:
Biopharma Biotechnology Health Care Manufacturing Medical Medical Device

Founded:
2001-01-01

Address:
Chapel Hill, North Carolina, United States

Country:
United States

Website Url:
http://www.askbio.com

Total Employee:
501+

Status:
Active

Contact:
+1 (919) 561-6210

Total Funding:
241.76 M USD

Technology used in webpage:
Person Schema Gravatar Profiles U.S. Server Location WP Engine Getty Images


Similar Organizations

avinger-logo

Avinger

Avinger is a medical device company engaged in developing catheter-based technologies and devices for treating vascular diseases.

bolt-threads-logo

Bolt Threads

Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future.

immunome-logo

Immunome

Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.

jenavalve-technology-logo

JenaValve Technology

JenaValve is a medical device company focused on the design and development of innovative transcatheter heart valve solutions

masimo-logo

Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products.

mediwound-logo

MediWound

MediWound is a biotechnology specialty company focused on developing, manufacturing and commercializing innovative wound care products.

ngm-biopharmaceuticals-logo

NGM Biopharmaceuticals

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

resmed-logo

ResMed

A global leader in digital health and connected medical devices, plus software solutions that support out-of-hospital care providers.

shine-medical-technologies-logo

SHINE Medical Technologies

SHINE Medical Technologies manufactures and supplies medical tracers and cancer treatment elements.

vaxart-logo

Vaxart

Vaxart is a biotechnology company that develops vaccine technology for the treatment of infectious diseases.


Current Advisors List

marianne-de-backer_image

Marianne De Backer Member Board of Directors ( A bayer company ) @ Asklepios BioPharmaceutical
Board_member
2020-11-01

Current Employees Featured

r-jude-samulski_image

R. Jude Samulski
R. Jude Samulski President, Chief Scientific Officer & Co-Founder @ Asklepios BioPharmaceutical
President, Chief Scientific Officer & Co-Founder
2003-01-01

david-c-venables_image

David C. Venables
David C. Venables President @ Asklepios BioPharmaceutical
President

martin-k-childers_image

Martin K. Childers
Martin K. Childers CMO @ Asklepios BioPharmaceutical
CMO

philip-dana_image

Philip Dana
Philip Dana Chief Human Resources Officer @ Asklepios BioPharmaceutical
Chief Human Resources Officer
2022-01-01

michael-l-kranda_image

Michael L. Kranda
Michael L. Kranda SVP CNS Practice Lead @ Asklepios BioPharmaceutical
SVP CNS Practice Lead
2010-07-01

not_available_image

Samuel Hopkins
Samuel Hopkins Sr. Vice President, Therapeutics @ Asklepios BioPharmaceutical
Sr. Vice President, Therapeutics
2018-03-01

mansuo-l-shannon_image

Mansuo L Shannon
Mansuo L Shannon Chief Scientific Officer @ Asklepios BioPharmaceutical
Chief Scientific Officer
2024-04-01

sheila-ann-mikhail_image

Sheila Ann Mikhail
Sheila Ann Mikhail Co-Founder @ Asklepios BioPharmaceutical
Co-Founder
2017-04-01

rebecca-boone_image

Rebecca Boone
Rebecca Boone Senior Vice President, Clinical Operations @ Asklepios BioPharmaceutical
Senior Vice President, Clinical Operations
2021-02-01

ken-macnamara_image

Ken Macnamara
Ken Macnamara SVP, UK Science and Site Lead @ Asklepios BioPharmaceutical
SVP, UK Science and Site Lead
2022-08-01

Founder


jude-samuski_image

Jude Samuski

r-jude-samulski_image

R. Jude Samulski

sheila-ann-mikhail_image

Sheila Ann Mikhail

Acquisitions List

Date Company Article Price
2020-04-22 Brainvectis Brainvectis acquired by Asklepios BioPharmaceutical N/A
2019-09-17 RoverMed BioSciences RoverMed BioSciences acquired by Asklepios BioPharmaceutical N/A
2019-08-13 Synpromics Ltd Synpromics Ltd acquired by Asklepios BioPharmaceutical N/A

Investors List

scottish-enterprise_image

Scottish Enterprise

Scottish Enterprise investment in Grant - Asklepios BioPharmaceutical

vida-ventures_image

Vida Ventures

Vida Ventures investment in Private Equity Round - Asklepios BioPharmaceutical

tpg-capital-asia_image

TPG Capital Asia

TPG Capital Asia investment in Private Equity Round - Asklepios BioPharmaceutical

muscular-dystrophy-association_image

Muscular Dystrophy Association

Muscular Dystrophy Association investment in Grant - Asklepios BioPharmaceutical

muscular-dystrophy-association_image

Muscular Dystrophy Association

Muscular Dystrophy Association investment in Grant - Asklepios BioPharmaceutical

Key Employee Changes

Date New article
2024-04-09 AskBio appoints new chief scientific officer

Official Site Inspections

http://www.askbio.com Semrush global rank: 2.55 M Semrush visits lastest month: 7.23 K

  • Host name: 172.99.75.43
  • IP address: 172.99.75.43
  • Location: San Antonio United States
  • Latitude: 29.4963
  • Longitude: -98.4004
  • Metro Code: 641
  • Timezone: America/Chicago
  • Postal: 78218

Loading ...

More informations about "Asklepios BioPharmaceutical"

Ask Bio - a Gene Therapy Company in RTP, North โ€ฆ

AskBio is headquartered in Research Triangle Park, North Carolina, a thriving biotechnology hub with nearly 600 life science companies. Research and development facilities are located in Philadelphia, Pennsylvania; Upper โ€ฆSee details»

Asklepios BioPharmaceutical - Crunchbase Company โ€ฆ

Organization. Asklepios BioPharmaceutical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Morningstar, Inc. โ€” AskBio Receives FDA Rare Pediatric Disease and โ€ฆSee details»

AskBio Announces Gustavo Pesquin as New CEO

Mar 9, 2023 Research Triangle Park, N.C.โ€“ March 9, 2023 โ€“ Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today announced that Gustavo Pesquin will become โ€ฆSee details»

AskBio Announces Gustavo Pesquin as New CEO - Bayer

Mar 9, 2023 Itโ€™s very energizing to join an organization with such purpose.โ€ About AskBio Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene โ€ฆSee details»

Asklepios BioPharmaceutical, Inc. (AskBio) | LinkedIn

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving ...See details»

Asklepios BioPharmaceutical, Inc. (AskBio) | LinkedIn

Asklepios BioPharmaceutical, Inc. (AskBio) | 34,827 followers on LinkedIn. Pioneering science to create transformative molecular medicines. | Asklepios BioPharmaceutical, Inc. (AskBio), a โ€ฆSee details»

Inside the $4B AskBio deal, the third largest buyout ever for an NC ...

Oct 27, 2020 Bayer will own AskBioโ€™s gene therapy platform, including a broad intellectual property portfolio and a contract development and manufacturing organization based on โ€ฆSee details»

First Patient Randomized in AskBio Phase II Gene Therapy Trial for ...

Feb 16, 2024 BERLIN & RESEARCH TRIANGLE PARK, N.C., February 16, 2024--Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and โ€ฆSee details»

Asklepios BioPharmaceutical, Inc. (AskBio): Culture | LinkedIn

Asklepios BioPharmaceutical, Inc. (AskBio) | 36,647 followers on LinkedIn. Pioneering science to create transformative molecular medicines. | Asklepios BioPharmaceutical, Inc. (AskBio), a โ€ฆSee details»

Bayer Acquires AskBio to Broaden Innovation Base in Cell and โ€ฆ

Oct 26, 2020 As a result of the acquisition, Bayer will own AskBioโ€™s gene therapy platform, including a broad intellectual property portfolio and established contract development and โ€ฆSee details»

Bayer buys cell & gene therapy firm AskBio for $4 billion

Oct 26, 2020 Bayer is making clear its ambitions in cell and gene therapy with a $4 billion acquisition of US biotech Asklepios BioPharmaceutical, also known as AskBio. AskBioโ€™s โ€ฆSee details»

First patient randomized in AskBio Phase II gene therapy trial for ...

Feb 16, 2024 About AskBio Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company โ€ฆSee details»

How 2 scientific pioneers teamed up to run AskBio, Bayer's new โ€ฆ

Jan 21, 2021 At AskBio, she's been named president of therapeutics. The role, however, lines up with High's current career ambitions. AskBio has the manufacturing capabilities, breadth of โ€ฆSee details»

AskBio Announces 11 Presentations at the American Society of โ€ฆ

May 11, 2023 Viralgen, an independently operated Contract Development and Manufacturing Organization (CDMO), was founded in 2017 as a joint venture between AskBio and Columbus โ€ฆSee details»

AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug โ€ฆ

Nov 7, 2024 Research Triangle Park, N.C., Nov. 07, 2024 (GLOBE NEWSWIRE) -- First patient dosed in Phase 1/Phase 2 LION-CS101 trial of AB-1003 in August 2023, with enrollment โ€ฆSee details»

Pioneers in Gene Therapy - Leadership Team - AskBio

The AskBio Team. The AskBio team is comprised of some of the most accomplished and experienced genetic researchers, clinicians and biopharmaceutical industry veterans. Our โ€ฆSee details»

AskBio Announces 11 Presentations at the European Society

Oct 17, 2024 Viralgen is a fully integrated contract development and manufacturing organization (CDMO) founded in 2017 as an independently operated subsidiary of Asklepios โ€ฆSee details»

Corporate Support & Charitable Contribution Guidelines - AskBio

AskBio will review charitable requests from U.S. nonprofit organizations described in Sections 501(c)(3) and 509 (a)(1)(2)(3) of the U.S. Internal Revenue Code including: ... Letter of โ€ฆSee details»

Gene Therapy Patient Advocacy & Information | AskBio

Email us at [email protected]. Facebook; LinkedIn; Twitter; YouTube; Inquiries. Media Center; Contact Us; Careers; Corporate Support; US Headquarters. 20 T.W. Alexander Drive โ€ฆSee details»

linkstock.net © 2022. All rights reserved